VETINDEX

Periódicos Brasileiros em Medicina Veterinária e Zootecnia

Onfalocele em bezerro neonato

Rech, Rodrigo DalminaCoelho, Isadora ComparsiDeponti, Patrícia SoaresAgnes, Andrey BerlesiCorrêa, Luís Felipe DutraPozzobon, RicardoSiqueira, Renata Farinelli deLeal, Marta Lizandra do Rêgo

Background: An omphalocele is a rare congenital malformation characterized by the protrusion of the abdominal contentsthrough the base of the umbilical cord. A defect in the midline of the abdomen results in the abdominal contents beingcovered by a membranous sac near the umbilical cord, which ultimately results in the failure of the abdominal organs toreturn to the abdominal cavity in the early gestational stages and the development of an omphalocele. This study aimed toaddress the diagnosis, medical-surgical management, and treatment for an omphalocele in a newborn calf.Case: A 2-day-old male Red Angus calf, weighing 35 kg, was referred to the HVU-UFSM. According to the owner, theanimal was born via normal delivery, had ingested milk, was alert, and had an enlarged pendulous abdomen at the umbilicus. Physical examination did not show any changes in vital functions; however, intestinal stasis was observed. Anin-depth examination revealed the presence of a round mass of tissue approximately 15 cm in diameter that was fillingthe remnant of the umbilical cord. This structure was covered by a thin, slightly dried membrane that isolated the contentsfrom the external environment. On palpation, the mass was firm and non-reducible, and an omphalocele was suspected.Given the severity of the condition, the animal immediately underwent an emergency surgical procedure to correct thecongenital defect. The surgery involved placing the intestinal loops that were present inside the sac in the abdominal cavity. At the end of the procedure, the animal was placed in a quadrupedal position to better assess omphalocele reduction.Postoperatively, the following medications were administered: a single dose of an analgesic along with a dipyrone andhyoscine-based antispasmodic (25 mg/kg, IM), an enrofloxacin-based antibiotic (2.5 mg/kg, IM) once a day for 7 days...(AU)

Texto completo